Our data suggest that direct cell-to-cell transfer of biomolecules play roles in providing a survival advantage to cancer cells during chemotherapy and targeting CD44 and/or MCT1 may be a plausible strategy to overcome drug resistance and metastasis in pancreatic tumors. Here, SLC16A1 is linked to pancreatic neoplasm.